BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34565017)

  • 21. Error-corrected sequencing strategies enable comprehensive detection of leukemic mutations relevant for diagnosis and minimal residual disease monitoring.
    Crowgey EL; Mahajan N; Wong WH; Gopalakrishnapillai A; Barwe SP; Kolb EA; Druley TE
    BMC Med Genomics; 2020 Mar; 13(1):32. PubMed ID: 32131829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
    Jiang L; Pallavajjala A; Huang J; Haley L; Morsberger L; Stinnett V; Hardy M; Park R; Ament C; Finch A; Shane A; Parish R; Nozari A; Long P; Adams E; Smith K; Parimi V; Dougaparsad S; Long L; Gocke CD; Zou YS
    J Mol Diagn; 2021 Apr; 23(4):467-483. PubMed ID: 33577993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of Noonan syndrome and related disorders using target next generation sequencing.
    Lepri FR; Scavelli R; Digilio MC; Gnazzo M; Grotta S; Dentici ML; Pisaneschi E; Sirleto P; Capolino R; Baban A; Russo S; Franchin T; Angioni A; Dallapiccola B
    BMC Med Genet; 2014 Jan; 15():14. PubMed ID: 24451042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
    Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
    Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.
    Lin PH; Li HY; Fan SC; Yuan TH; Chen M; Hsu YH; Yang YH; Li LY; Yeh SP; Bai LY; Liao YM; Lin CY; Hsieh CY; Lin CC; Lin CH; Lien MY; Chen TT; Ni YH; Chiu CF
    Cancer Med; 2017 Feb; 6(2):349-360. PubMed ID: 28070990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Alterations Detected by Targeted Next-generation Sequencing and Their Clinical Implications in Neuroblastoma.
    Koh KN; Lee JY; Lim J; Shin J; Kang SH; Suh JK; Kim H; Im HJ; Namgoong JM; Kim DY; Jang SJ; Chun SM
    Anticancer Res; 2020 Dec; 40(12):7057-7065. PubMed ID: 33288603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
    Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
    Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation sequencing for the diagnosis of patients with congenital multiple anomalies and / or intellectual disabilities.
    Suga K; Imoto I; Ito H; Naruto T; Goji A; Osumi K; Tokaji N; Homma Y; Ono A; Ichihara Y; Shono M; Mori T; Urushihara M; Nakagawa R; Hayabuchi Y; Kagami S
    J Med Invest; 2020; 67(3.4):246-249. PubMed ID: 33148896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.
    Rossi D; Ciardullo C; Gaidano G
    Semin Cancer Biol; 2013 Dec; 23(6):422-30. PubMed ID: 23665546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Next-Generation Sequencing for Detecting
    Afrin S; Zhang CRC; Meyer C; Stinson CL; Pham T; Bruxner TJC; Venn NC; Trahair TN; Sutton R; Marschalek R; Fink JL; Moore AS
    Mol Cancer Res; 2018 Feb; 16(2):279-285. PubMed ID: 29133595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing.
    Ghosh A; Schlecht H; Heptinstall LE; Bassett JK; Cartwright E; Bhaskar SS; Urquhart J; Broomfield A; Morris AA; Jameson E; Schwahn BC; Walter JH; Douzgou S; Murphy H; Hendriksz C; Sharma R; Wilcox G; Crushell E; Monavari AA; Martin R; Doolan A; Senniappan S; Ramsden SC; Jones SA; Banka S
    Arch Dis Child; 2017 Nov; 102(11):1019-1029. PubMed ID: 28468868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young.
    Szopa M; Ludwig-Gałęzowska A; Radkowski P; Skupień J; Zapała B; Płatek T; Klupa T; Kieć-Wilk B; Borowiec M; Młynarski W; Wołkow P; Małecki MT
    Pol Arch Med Wewn; 2015; 125(11):845-51. PubMed ID: 26552609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.
    Mansilla MA; Sompallae RR; Nishimura CJ; Kwitek AE; Kimble MJ; Freese ME; Campbell CA; Smith RJ; Thomas CP
    Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31738409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetics in the diagnosis of hematologic malignancies.
    Clare N; Hansen K
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):785-807. PubMed ID: 7961291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
    Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
    Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain.
    Gonzalez-Quereda L; Rodriguez MJ; Diaz-Manera J; Alonso-Perez J; Gallardo E; Nascimento A; Ortez C; Natera-de Benito D; Olive M; Gonzalez-Mera L; Munain AL; Zulaica M; Poza JJ; Jerico I; Torne L; Riera P; Milisenda J; Sanchez A; Garrabou G; Llano I; Madruga-Garrido M; Gallano P
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing.
    Park E; Shim HS
    Cancer Res Treat; 2020 Apr; 52(2):543-551. PubMed ID: 31726498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.
    Slack GW
    Surg Pathol Clin; 2023 Jun; 16(2):433-442. PubMed ID: 37149368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.